After yesterday's market close, the Birmingham, AL-based operator of inpatient rehabilitation hospitals posted adjusted earnings of 59 cents per share, in line with analysts' expectations.
Revenue for the period was $879.3 million, exceeding Wall Street's expectations of $858.5 million.
"We were very pleased with the strong organic growth in both segments and the contributions from the rehabilitation hospitals acquired from Reliant Hospital Partners and the home health and hospice agencies acquired from CareSouth Health System in the fourth quarter," CEO Jay Grinney said in a statement.
For 2016, HealthSouth forecasts adjusted earnings per diluted share between $2.32 and $2.44 on revenue in the range of $3.55 billion to $3.65 billion.
The company's inpatient rehabilitation hospitals offer rehabilitative care for diagnoses such as physical and cognitive disabilities and injuries due to medical conditions, such as strokes, hip fractures and head injuries.
About 1.23 million of the company's shares were traded by this afternoon, compared to its average volume of 875,575 shares per day.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.
This is driven by some important positives, which should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks covered.
The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, good cash flow from operations and increase in net income.
The team believes its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HLS